Related references
Note: Only part of the references are listed.IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Vasilena Gocheva et al.
GENES & DEVELOPMENT (2010)
Pharmacologic Administration of Interleukin-2 Inducing a Systemic Autophagic Syndrome?
Antonio Romo de Vivar Chavez et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
David G. DeNardo et al.
CANCER CELL (2009)
The promise and potential pitfalls of chimeric antigen receptors
Michel Sadelain et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
CD4+ T-cell-mediated anti-tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis
Sheng Zhang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
IMMUNOHISTOCHEMICAL EXPRESSION OF INTERLEUKIN-4,-6,-8, AND-12 IN INFLAMMATORY CELLS IN SURROUNDING INVASIVE FRONT OF ORAL SQUAMOUS CELL CARCINOMA
Marcos Vinicius Macedo de Oliveira et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Endogenous Interleukin-4 Promotes Tumor Development by increasing Tumor Cell Resistance to Apoptosis
Zhiguang Li et al.
CANCER RESEARCH (2008)
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4
M. Todaro et al.
CELL DEATH AND DIFFERENTIATION (2008)
Retargeting of human T cells to tumor-associated MUC1: The evolution of a chimeric antigen receptor
Scott Wilkie et al.
JOURNAL OF IMMUNOLOGY (2008)
Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation
Agnes Shuk Yee Lo et al.
MOLECULAR IMMUNOLOGY (2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells
Soo Ok Lee et al.
PROSTATE (2008)
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
Matthias T. Stephan et al.
NATURE MEDICINE (2007)
Effect of an interieukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
Sally Wenzel et al.
LANCET (2007)
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
Matilde Todaro et al.
CELL STEM CELL (2007)
Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4
Dawn E. Post et al.
CANCER RESEARCH (2007)
Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma
Julie R. Park et al.
MOLECULAR THERAPY (2007)
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51
David M. Kurtz et al.
LEUKEMIA & LYMPHOMA (2007)
The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?
S. Olver et al.
TISSUE ANTIGENS (2007)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
MA Pulè et al.
MOLECULAR THERAPY (2005)
Early immune response and regulation of IL-2 receptor subunits
M Hughes-Fulford et al.
CELLULAR SIGNALLING (2005)
Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-α transduction
J Eguchi et al.
GENE THERAPY (2005)
eInterleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions
O Prokopchuk et al.
BRITISH JOURNAL OF CANCER (2005)
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins
C Conticello et al.
JOURNAL OF IMMUNOLOGY (2004)
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
MR Verneris et al.
BLOOD (2004)
Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
PF Robbins et al.
JOURNAL OF IMMUNOLOGY (2004)
Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancer
NS Majhail et al.
INVESTIGATIONAL NEW DRUGS (2004)
Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector
AL Szymczak et al.
NATURE BIOTECHNOLOGY (2004)
Tumor rejection by modulation of tumor stromal fibroblasts
T Schüler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
RJ Brentjens et al.
NATURE MEDICINE (2003)
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation
NM Haynes et al.
JOURNAL OF IMMUNOLOGY (2002)
Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism
K Suzuki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells
JL Gooch et al.
NEOPLASIA (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells
K Srivannaboon et al.
BLOOD (2001)
Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells
S Gasser et al.
JOURNAL OF IMMUNOLOGY (2000)
Cytokine variations in patients with hormone treated prostate cancer
GJ Wise et al.
JOURNAL OF UROLOGY (2000)
Share Paper
